(2023)
Treatment outcome and prognostic factors in relapsed pediatric acute myeloid leukemia.
Blood Research.
1,
1
(2023)
Current Status and Physicians' Perspectives of Childhood Cancer Survivorship in Korea: A Nationwide Survey of Pediatric Hematologists/Oncologists.
JOURNAL OF KOREAN MEDICAL SCIENCE.
38,
29
(2023)
Methionine metabolism and endocrine function of the pituitary gland in patients with suprasellar germinoma.
PLOS ONE.
18,
7
(2023)
High-dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma.
PEDIATRIC BLOOD & CANCER.
70,
4
(2023)
Minimal dose of hematopoietic stem cell transplantation without myelosuppressive conditioning for T-B+NK- severe combined immunodeficiency.
CLINICAL IMMUNOLOGY.
(2023)
Self‑reported physical activity behaviors of childhood cancer survivors: comparison to a general adolescent population in Korea.
SUPPORTIVE CARE IN CANCER.
(2022)
Postchemotherapy gross residual tumor in non-high-risk neuroblastoma: Clinical significance and the role of adjuvant therapy.
PEDIATRIC BLOOD & CANCER.
69,
11
(2022)
EPIDEMIOLOGIC AND CLINICAL OUTCOMES OF PEDIATRIC RENAL TUMORS IN KOREA: A RETROSPECTIVE ANALYSIS OF THE KOREAN PEDIATRIC HEMATOLOGY AND ONCOLOGY GROUP (KPHOG) DATA.
PEDIATRIC BLOOD & CANCER.
69,
1
(2022)
Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma.
SCIENTIFIC REPORTS.
12,
1
(2022)
Dual role of ERK2/NF-kappa B signaling in TRAIL sensitivity.
AMERICAN JOURNAL OF CANCER RESEARCH.
12,
7
(2022)
Safety and Efficacy of Pegteograstim on Chemotherapy-induced Neutropenia in Children and Adolescents With Solid Tumors.
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY.
44,
2
(2022)
Risk Stratification of Childhood Medulloblastoma Using Integrated Diagnosis: Discrepancies With Clinical Risk Stratification.
JOURNAL OF KOREAN MEDICAL SCIENCE.
37,
7
(2022)
Value of C-11 methionine PET/CT in patients with intracranial germinoma.
PLOS ONE.
17,
2
(2022)
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma.
CANCER RESEARCH AND TREATMENT.
54,
1
(2022)
Absolute Neutrophil Count after the First Chemotherapy Cycle as a Surrogate Marker for Treatment Outcomes in Patients with Neuroblastoma.
CANCER RESEARCH AND TREATMENT.
54,
1
(2021)
Clinical implication of residual MIBG-positive disease in the follow-up of high-risk neuroblastoma treated with tandem high-dose chemotherapy and autologous stem cell transplantation.
PEDIATRIC BLOOD & CANCER.
1,
1
(2021)
Risk factors and outcomes of cytomegalovirus infection in children post cord blood transplantation with focus on impact of graft-versus-host disease and immunosuppressants.
ANNALS OF HEMATOLOGY.
101,
2
(2021)
Application of an LC-MS/MS Method for the Simultaneous Quantification of Homovanillic Acid and Vanillylmandelic Acid for the Diagnosis and Follow-Up of Neuroblastoma in 357 Patients.
MOLECULES.
26,
11
(2021)
Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia.
JOURNAL OF KOREAN MEDICAL SCIENCE.
36,
19
(2021)
Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years.
CANCER RESEARCH AND TREATMENT.
53,
2
Conference Paper
(2023)
Germline Functional Variants Contribute to Somatic Mutation and Outcomes in Neuroblastoma.
대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2023)
HRAS 돌연변이의 체세포 모자이크 현상(Somatic Mosaiclsm of HRAS Mutation)으로 인한 소아의 횡문근 육종 증례.
대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2023)
두개 내 배세포종 치료 시 관해유도 항암요법의 강화를 통한 방사선치료 선량의 감소: SMC G-18 연구의 예비 보고.
대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2023)
영아 수모세포종의 치료 결과 및 예후 인자 분석 : 대한소아혈액종양학회(KPHOG) 뇌종양위원회 다기관 후향적 연구.
대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
Clinical Implication of Residual MIBG-Positive Disease in the Follow-Up of High-Risk Neuroblastoma Treated with Tandem High-Dose Chemotherapy and Autologous Stem Cel Transplantation.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
98명의 소아 고형암 환자들을 대상으로 한 생식세포 암소인 유전자 변이 차세대 염기서열 분석 연구: 단일 기관의 경험.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
Current status and physician's perspective of childhood cancer survivorship: Nation-wide survey of pediatric oncologists in Korea.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
Excellent outcome of pediatric patients with de novo acute myeloid leukemia treated with a stratified strategy based on prognostic groups: A multicenter prospective study (AML 2012).
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
소아암 생존자의 청력 변화 및 악화 요인에 대한 단일 기관 연구.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
소아청소년 급성 림프모구백혈병 생존자에서 후기 내분비 합병증 분석.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
신경모세포종 환자의 circulating cell-free DNA를 이용한 chromosomal instability 평가 및 임상적 유용성 확인.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
재발한 신경모세포종 환자에서 131-I MIBG 치료 및 반일치 동종조혈모세포이식 병합요법의 예후인자.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2021)
저위험 혹은 중간위험군 신경모세포종에서 항암치료 후 잔존존양과 후속치료의 임상적 의의.
제71차 대한소아청소년과학회 추계학술대회.
KOREA, REPUBLIC OF
(2020)
Low-grade non-Hodgkin lymphoma in children and adolescents: a single institute experience.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
NUDT15 변이 유전자형을 가진 급성림프모구백혈병 환자에서 치료 표지자로서 DNA-thioguanine nucleotide의 이용.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
Risk stratification of medulloblastoma using integrated diagnosis: discrepancy with clinical risk stratification.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
Upfront unrelated cord blood transplantation is feasible in children with acquirded severe aplastic anemia.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
소아 고형 종양 치료 후 이차암의 발생율 및 위험인자.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
재발한 고위험군 신경모세포종 환자에서 αβ T세포 제거 반일치 동종조혈모세포이식 후 dinutuximab beta 면역 치료를 시행한 4례.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
(2020)
중증복합면역결핍병 환자들에서 전처치를 생략하고 극소량의 미조작 골수혈을 이용한 성공적인 동종 조혈모세포이식술.
제70차 대한소아청소년과학회 추계학술대회 초록집.
KOREA, REPUBLIC OF
